Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion.
Upon completion of the merger, Wright shareholders will own approximately 52% of the shares of the combined company and Tornier shareholders will own approximately 48%. The combined company will leverage the global strengths of both product brands as a pure play Extremities-Biologics business.
Following the closing of the transaction, the combined company will conduct business as Wright Medical Group N.V. to be incorporated in the Netherlands, where Tornier has been incorporated and headquartered for approximately 8 years. Both companies agreed that maintaining Tornier’s domicile best supported the growth strategy driving the merger. Over the long term, it is anticipated that this structure will provide the company with more accessible cash flow, enhancing its ability to innovate and grow, creating long-term shareholder value. The transaction is subject to customary closing conditions and is expected to close in the first half of 2015.
Source: www.stibbe.com
